文献速递睡眠呼吸障碍

中重度阻塞性睡眠呼吸暂停患者口腔矫治器治疗有效的预测因素

Predictive Factors for Efficacious Oral Appliance Therapy in Moderate to Severe Obstructive Sleep Apnea Patients.
PubMed 文献 · Laryngoscope · 2021-02-19

这项回顾性研究纳入347例接受保留型口腔矫治器(OA)治疗的中重度OSAHS患者,由耳鼻咽喉科医生完成操作。结果显示OA可显著降低平均AHI(-14.9/hr,P<.0001),50%AHI下降率为65.2%,AHI≤5/hr率为26.1%;初始AHI和BMI较高者AHI下降更显著,但下降幅度与年龄及下颌前移程度无关。

要点

  • OA治疗中重度OSAHS可使平均AHI降低14.9/hr(P<.0001)。
  • 50%AHI下降率为65.2%,AHI≤5/hr率为26.1%。
  • 初始AHI和BMI较高者AHI下降更显著,但与年龄及下颌前移程度无关。

核心结论

  • OA是治疗中重度OSAHS有效且耐受性良好的方法,约三分之二病例可实现AHI下降≥50%,应考虑在更多病例中应用。

研究设计与样本

  • 回顾性研究,纳入347例接受保留型OA治疗的中重度OSAHS患者,操作全部由耳鼻咽喉科医生完成。

主要发现

  • OA治疗后平均AHI降低14.9/hr(P<.0001)。
  • 初始AHI较高和初始BMI较高的患者AHI下降更显著,下降幅度与年龄无关,与下颌前移程度不成比例。
  • 50%AHI下降率为65.2%,AHI≤5/hr率为26.1%,AHI下降<50%且残余AHI>10/hr率为50.1%。
  • 7.8%患者AHI升高,1.5%出现不良反应,7.8%因无效等原因停用OA。
  • 增加下颌前移量有时有效,但未显著降低AHI。

关键数值与推荐

  • 50%AHI下降率65.2%,AHI≤5/hr率26.1%,AHI下降<50%且残余AHI>10/hr率50.1%。
  • 平均AHI降低14.9/hr(P<.0001)。
  • 7.8%患者AHI升高,1.5%出现不良反应,7.8%停用OA。

临床怎么用

  • 对中重度OSAHS患者,OA可作为有效治疗选择,尤其初始AHI和BMI较高者可能获益更明显。
  • 需关注7.8%患者AHI升高及7.8%停用率,治疗中应评估疗效与耐受性。
  • 增加下颌前移量不一定显著降低AHI,需个体化调整。

局限性

  • 回顾性研究设计,证据等级为4级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: Oral appliances (OAs) are a treatment for obstructive sleep apnea hypopnea syndrome (OSAHS). The main objective of the study was to determine the predictive factors of OA efficacy. The secondary objective was to measure the efficacy rates and determine OAs' tolerance and dropout. STUDY DESIGN: Retrospective study. METHODS: Efficacy results of the OAs based on the apnea hypopnea index (AHI) reduction, complications, and dropout rates were retrospectively collected from 347 patients with a moderate to severe OSAHS treated by a retention OA. The procedure was entirely performed by otolaryngologists. RESULTS: The AHI with OA was more significantly reduced in patients with a higher initial AHI and a higher initial body mass index but reduction was not related to age and not proportional to the degree of mandibular advancement. The 50% AHI reduction rate after OA was 65.2%, the AHI ≤5/hr rate after OA was 26.1%, and the <50% AHI reduction and residual AHI > 10/hr rate was 50.1%. The OA significantly reduced the mean AHI (-14.9/hr, P < .0001). In 7.8% of patients, the AHI increased with OA. Seven patients (1.5%) experienced adverse effects. Thirty-seven (7.8%) patients stopped using OA mainly because of its ineffectiveness. Advancement can be considered beyond the initial maximal advancement. It can be effective sometimes; however, increasing advancement did not significantly reduce AHI. CONCLUSIONS: OA is an effective and well-tolerated treatment for moderate to severe OSAHS. This treatment was effective for reduction of the AHI ≥50% in two-thirds of cases studied and it should be considered in more cases. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E2089-E2096, 2021.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Buiret G, Bechara M, Plouin-Gaudon I, et al. Predictive Factors for Efficacious Oral Appliance Therapy in Moderate to Severe Obstructive Sleep Apnea Patients. Laryngoscope. 2021. PMID: 33605446. doi:10.1002/lary.29439

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。